Blog

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

Condition:   Prostate Cancer Metastatic
Interventions:   Drug: REGN2810;   Drug: Degarelix;   Drug: Leuprolide Acetate;   Drug: Docetaxel
Sponsors:   Mark Stein;   Regeneron Pharmaceuticals
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019 / by / in
Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

Conditions:   Subacromial Impingement;   Subacromial Impingement Syndrome
Interventions:   Drug: Ketorolac Tromethamine;   Drug: Methylprednisolone Acetate
Sponsor:   The University of Texas Medical Branch, Galveston
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019 / by / in
Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

Condition:   Respiratory Syncytial Virus (RSV)
Interventions:   Biological: RSV ΔNS2/Δ1313/I1314L Vaccine;   Biological: RSV 6120/ΔNS2/1030s Vaccine;   Biological: RSV 276 Vaccine;   Biological: Placebo
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019 / by / in
Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

Conditions:   Diffuse Large B-cell Lymphoma;   Acute Myeloid Leukemia;   Non-Hodgkin’s Lymphoma
Interventions:   Drug: Venetoclax;   Drug: Selinexor
Sponsors:   Michael Byrne;   Karyopharm Therapeutics Inc;   AbbVie
Not yet recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019 / by / in